Latest Period
Q4 2025
Security Snapshot
Conduit Pharmaceuticals Inc. - Common Stock, par value $0.0001 per share (CDT) Institutional Ownership
CUSIP: 20678X106
13F Institutional Holders and Ownership History from Q3 2023 to Q4 2025
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$0.05
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- CDT on Nasdaq
- Shares outstanding
- 6,717,455
- Price per share
- $0.05
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 0
- Total reported value
- $0
- Share change
- -837,827
- Value change
- -$99,284
- Number of holders
- 0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- CDT - Conduit Pharmaceuticals Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 20678X106.
- 0 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 1 to 0 between Q3 2025 and Q4 2025.
- Reported value moved from $99,284 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 20678X106?
CUSIP 20678X106 identifies CDT - Conduit Pharmaceuticals Inc. - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 20678X106:
Significant Owners of Conduit Pharmaceuticals Inc. - Common Stock, par value $0.0001 per share (CDT) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ASTRAZENECA PLC | 1.1% | $3,340 | 73,892 | AstraZeneca PLC | 31 Mar 2025 |
Institutional Holders of Conduit Pharmaceuticals Inc. - Common Stock, par value $0.0001 per share (CDT) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 0 | $0 | -$99,284 | $0.05 | 0 |
| 2025 Q3 | 837,827 | $99,284 | +$99,284 | $0.12 | 1 |
| 2025 Q2 | 0 | $0 | -$904 | $0.05 | 0 |
| 2025 Q1 | 20,000 | $904 | -$596,632 | $0.05 | 1 |
| 2024 Q4 | 8,729,799 | $598,663 | +$318,643 | $0.07 | 38 |
| 2024 Q3 | 4,047,175 | $479,215 | -$31,315 | $0.12 | 32 |
| 2024 Q2 | 2,915,519 | $3,091,142 | +$1,222,322 | $1.06 | 28 |
| 2024 Q1 | 1,611,148 | $5,914,895 | +$851,869 | $3.67 | 17 |
| 2023 Q4 | 1,375,057 | $6,263,930 | +$6,231,928 | $4.55 | 11 |
| 2023 Q3 | 5,353 | $32,002 | +$32,002 | $5.97 | 3 |